---
title: "Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296607586.md"
description: "Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Laboratories (ABT) with a $112 price target. ABT shares closed at $114.14. Biegelsen, who covers healthcare stocks including Johnson & Johnson and Medtronic, has a 53.68% success rate. The broader Street consensus for ABT is a Strong Buy with an average price target of $121.79."
datetime: "2026-08-21T10:48:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296607586.md)
  - [en](https://longbridge.com/en/news/296607586.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296607586.md)
generator: "portal-rs"
---

# Wells Fargo Keeps Their Buy Rating on Abbott Laboratories (ABT)

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories, with a price target of $112.00. The company’s shares closed yesterday at $114.14.

### Summer Sale - Claim 70% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Biegelsen covers the Healthcare sector, focusing on stocks such as Abbott Laboratories, Johnson & Johnson, and Medtronic. According to TipRanks, Biegelsen has an average return of 4.2% and a 53.68% success rate on recommended stocks. 

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Laboratories with a $121.79 average price target.

### Related Stocks

- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Xcel Wealth Management LLC Cuts Stock Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/296700328.md)
- [Jefferies Sticks to Their Buy Rating for Abbott Laboratories (ABT)](https://longbridge.com/en/news/296645903.md)
- [Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296461096.md)
- [Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative?](https://longbridge.com/en/news/296546525.md)
- [D.A. Davidson & CO. Sells 38,578 Shares of Abbott Laboratories $ABT](https://longbridge.com/en/news/296694848.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**